Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.
Allogeneic and autologous bone marrow and blood cell transplants are increasingly used treatments for cancer and disorders of bone marrow and immune function. This is largely due to use of autotransplants to treat common diseases such as breast cancer. The use of blood cells alone for autotransplants was also a significant change in the past 5 years. The IBMTR and ABMTR continue to provide a unique resource for studying outcomes and trends in allogeneic and autologous bone marrow and blood cell transplants.
Passweg
J R
JR
IBMTR and ABMTR Statistical Center, Health Policy Institute, Medical College of Wisconsin, Milwaukee, USA.
Rowlings
P A
PA
Armitage
J O
JO
Gale
R P
RP
Pelz
C J
CJ
Sobocinski
K A
KA
Klein
J P
JP
Zhang
M J
MJ
Horowitz
M M
MM
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000401:mortality / Q000628:therapy; D016026:Bone Marrow Transplantation / Q000401:mortality / Q000706:statistics & numerical data; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000401:mortality / Q000706:statistics & numerical data; D006689:Hodgkin Disease / Q000401:mortality / Q000628:therapy; D006801:Humans; D007390:International Agencies; D007938:Leukemia / Q000401:mortality / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009656:North America; D012042:Registries; D015996:Survival Rate; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous